Webinar: WV Monkeypox Update

Click here to view the archived webinar. 

Recently, the HHS Secretary Xavier Becerra declared the ongoing monkeypox outbreak a public health emergency in the U.S., and the case count has grown to more than 11,000 cases nationwide. Last week, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the JYNNEOS vaccine. The EUA allows healthcare providers to administer the vaccine by intradermal injection for individuals 18 years of age and older who are at high risk for monkeypox infection. In addition, the Centers for Disease Control and Prevention (CDC) has released Interim Clinical Considerations for Use of JYNNEOS and ACAM2000 Vaccines during the 2022 U.S. Monkeypox Outbreak that provides guidance for using the alternative (intradermal) regimen, as well as the standard (subcutaneous) regimen for JYNNEOS vaccine.

During this webinar, the speaker will provide a situational update on the monkeypox outbreak in the U.S. and WV along with an overview of recommendations for testing, treatment, and vaccination.

Webinar Objectives:

At the conclusion of this program, participants will be able to:

1. Describe the epidemiology of the 2022 monkeypox outbreak;
2. Recognize the common clinical presentations of monkeypox infections in the 2022 outbreak;
3. Describe diagnostic testing recommendations and treatment options for monkeypox infections; and
4. Summarize monkeypox vaccination recommendations and vaccine access. 

Speaker:

Shannon McBee, MPH, CHES, State Epidemiologist, West Virginia Bureau for Public Health

Related materials:

• Presentation slides
• HEALTH ADVISORY #202: WV Monkeypox Outbreak Update
• WV Monkeypox Vaccine Strategy 8.22.22
• Monkey Pox-Infection Control and Prevention: Healthcare Personnel (HCP) Exposure Risk Assessment
• JYNNEOS EUA Healthcare Provider Fact Sheet
• JYNNEOS Smallpox and Monkeypox Vaccine Subcutaneous Vaccine Preparation and Administration Summary: STANDARD REGIMEN
• JYNNEOS Smallpox and Monkeypox Vaccine Intradermal Vaccine Preparation and Administration Summary: ALTERNATIVE DOSING REGIMEN

In case you missed it:

Click here to view the archived webinar. CEUs are no longer available for this event.

Continuing Education:

In support of improving patient care, this activity has been planned and implemented by WV Immunization Network and CAMC Institute for Academic Medicine. CAMC Institute for Academic Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians – The CAMC Institute for Academic Medicine designates this virtual activity for a maximum of 1 hour for AMA PRA Category I Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses – The CAMC Institute for Academic Medicine is an approved provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This offering has been approved for 1 contact hour (JA0026-22-22-474)

Pharmacy – The CAMC Institute for Academic Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To receive credit, participants must complete the sign-in sheet, attend each session and complete an evaluation. ACPE credits will be posted online to the CPE Monitor within six (6) weeks following the activity. This knowledge-based activity provides 1 contact hour (JA0006133-9999-22-076-L06-P).